Family · Pharmaceutical analytical standards
Dutasteride
An inhibitor of all three forms of 5-alpha reductase, the enzyme that converts testosterone into dihydrotestosterone. It was approved in the United States in 2001 for benign prostatic hyperplasia. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.
Did you know?It lowers dihydrotestosterone in the blood by about 90% and has a half-life of about five weeks: it stays in the body for months after the last dose.
No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
